Commodore Capital LP
- SEC CIK
- 0001831942
- Latest filing
- Aug 14, 2026
Holdings in Q4 2021
Holdings as of Dec 31, 2021, filed Feb 14, 2022. Long positions only; changes compare share counts with Q3 2021.
- Positions
- 25
- −4 vs. Q3 2021
- Portfolio value
- $431.8M
- +$52.5M (+13.8%) vs. Q3 2021
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| BCLS Acquisition CorpG0904B105 | COM CL A | 250,000 | $2.45M | 0.6% | 00.0% | Unchanged | – |
| PMVPPMV Pharmaceuticals, Inc. | COM | 125,000 | $2.89M | 0.7% | 00.0% | Unchanged | History |
| MREOMereo BioPharma Group plc | SPON ADS | 1,954,970 | $3.13M | 0.7% | −17,988−0.9% | Reduced | History |
| GNCAGenocea Biosciences, Inc. | COM NEW | 3,079,756 | $3.57M | 0.8% | 00.0% | Unchanged | History |
| IVAInventiva S.A. | ADS | 262,658 | $3.59M | 0.8% | 00.0% | Unchanged | History |
| DYNDyne Therapeutics, Inc. | COM | 305,125 | $3.63M | 0.8% | 00.0% | Unchanged | History |
| KRONKronos Bio, Inc. | COM | 298,839 | $4.06M | 0.9% | 00.0% | Unchanged | History |
| KALVKalVista Pharmaceuticals, Inc. | COM | 312,553 | $4.13M | 1.0% | 00.0% | Unchanged | History |
| ALLKAllakos Inc. | COM | 815,667 | $7.99M | 1.8% | +815,667 | New | History |
| TNYATenaya Therapeutics, Inc. | COM | 513,930 | $9.74M | 2.3% | 00.0% | Unchanged | History |
| TCDATricida, Inc. | COM | 1,247,043 | $11.9M | 2.8% | +1,247,043 | New | History |
| CELCCelcuity Inc. | COM | 920,464 | $12.1M | 2.8% | 00.0% | Unchanged | History |
| CCCCC4 Therapeutics, Inc. | COM STK | 481,094 | $15.5M | 3.6% | 00.0% | Unchanged | History |
| VTGNVistagen Therapeutics, Inc. | COM NEW | 8,464,999 | $16.5M | 3.8% | +3,341,490+65.2% | Added | History |
| STSASatsuma Pharmaceuticals, Inc. | COM | 3,711,286 | $16.7M | 3.9% | +592,525+19.0% | Added | History |
| VRDNViridian Therapeutics, Inc. | COM | 847,683 | $16.8M | 3.9% | +180,009+27.0% | Added | History |
| CBAYCymaBay Therapeutics, Inc. | COM | 5,419,896 | $18.3M | 4.2% | +1,250,000+30.0% | Added | History |
| COGTCogent Biosciences, Inc. | COM | 2,281,315 | $19.6M | 4.5% | +368,804+19.3% | Added | History |
| Bellus Health Inc New07987C204 | COM NEW | 3,124,613 | $25.2M | 5.8% | +3,124,613 | New | – |
| PTGXProtagonist Therapeutics, Inc | COM | 805,573 | $27.6M | 6.4% | +307,494+61.7% | Added | History |
| CYTKCytokinetics Inc | COM NEW | 704,537 | $32.1M | 7.4% | −92,041−11.6% | Reduced | History |
| XENEXenon Pharmaceuticals Inc. | COM | 1,090,126 | $34.1M | 7.9% | +510,694+88.1% | Added | History |
| ACRSAclaris Therapeutics, Inc. | COM | 2,672,346 | $38.9M | 9.0% | +482,055+22.0% | Added | History |
| MRUSMerus N.V. | COM | 1,498,890 | $47.7M | 11.0% | +780,754+108.7% | Added | History |
| ISEEIVERIC bio, Inc. | COM | 3,217,163 | $53.8M | 12.5% | +467,026+17.0% | Added | History |
Sold out since Q3 2021 (7)
Positions held at the end of Q3 2021 that are gone from this filing.
| Security | Class | Shares in Q3 2021 | Value in Q3 2021 | % of portfolio in Q3 2021 | History |
|---|---|---|---|---|---|
| DRNADicerna Pharmaceuticals Inc | COM | 1,292,251 | $26.1M | 6.9% | History |
| KURAKura Oncology, Inc. | COM | 999,433 | $18.7M | 4.9% | History |
| CLDXCelldex Therapeutics, Inc. | COM NEW | 248,207 | $13.4M | 3.5% | History |
| IOVAIovance Biotherapeutics, Inc. | COM | 362,869 | $8.95M | 2.4% | History |
| RVMDRevolution Medicines, Inc. | COM | 226,228 | $6.22M | 1.6% | History |
| ATXSAstria Therapeutics, Inc. | COM | 239,270 | $2.12M | 0.6% | History |
| SPRYARS Pharmaceuticals, Inc. | COM | 97,143 | $969.0K | 0.3% | History |